SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-271914
Filing Date
2023-11-07
Accepted
2023-11-07 07:15:01
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d540306d8k.htm   iXBRL 8-K 26060
2 EX-99.1 d540306dex991.htm EX-99.1 51698
6 GRAPHIC g540306g1107004848959.jpg GRAPHIC 3967
  Complete submission text file 0001193125-23-271914.txt   221884

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20231107.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20231107_lab.xml EX-101.LAB 19501
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20231107_pre.xml EX-101.PRE 12163
8 EXTRACTED XBRL INSTANCE DOCUMENT d540306d8k_htm.xml XML 3606
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 231381536
SIC: 2836 Biological Products, (No Diagnostic Substances)